[HTML][HTML] Empagliflozin treatment of cardiotoxicity: A comprehensive review of clinical, immunobiological, neuroimmune, and therapeutic implications

Z Vaziri, K Saleki, C Aram, P Alijanizadeh… - Biomedicine & …, 2023 - Elsevier
Cancer and cardiovascular disorders are known as the two main leading causes of mortality
worldwide. Cardiotoxicity is a critical and common adverse effect of cancer-related …

Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway

M Elsayed, YM Moustafa, ET Mehanna, RA Elrayess… - Life Sciences, 2024 - Elsevier
Aim Cardiac fibrosis is characterized by excessive accumulation of fibrous tissue,
particularly collagens, in the myocardium. Accumulated fibrous tissue renders myocardium …